Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by longondmxon Jan 24, 2014 10:06am

295 Views

Post# 22129458

The current share price drop

is caused by weak hands who do not want to wait for a bigger pay day. Patient holders will be rewarded.

The good news is that the asks are not that many...and those same sellers that are liquidating shares, would need to pay higher prices to get back in...so this merely presents a great buying opportunity for those wanting more or waiting to get in.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports